RxDoctor Payments Data

Rosemary Hansen

Adult Health · Buffalo, NYNPI 1548534001

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (33.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 81.7% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $23,108, 3.3 times the $6,974 reported in 2021. Among adult health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$40,212in general payments, 2019–2025

Across 419 payments — averaging $95.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$33K
  • Boston Scientific$2K
  • Medtronic$1K
  • Abbott$783
  • AOP Health US, LLC$590
  • Abiomed$324
  • plus $2K from 17 others

What the payments were for

  • Consulting fees$12,17530%
  • Speaking & faculty fees$1,8004%
  • Travel & lodging$13,43933%
  • Food & beverage$12,79932%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,212 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$30,383
Medicare patients
231
Services billed
305

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$13,826
ClopidogrelClopidogrel Bisulfate79$1,001
Metoprolol Succinate17$319
Furosemide24$202
Prednisone14$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$319$13,82616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.

Other adult health in Buffalo

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →